Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0LIYTM
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
XMT-2068
|
|||||
| Synonyms |
XMT2068; XMT 2068
Click to Show/Hide
|
|||||
| Organization |
Mersana Therapeutics, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
Antigen Name |
Undisclosed
|
|||
| Payload Name |
STING agonist
|
Payload Info | ||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Immunosynthen.
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.